Brief: Cervomed Announces Completion Of Enrollment In Phase 2B Rewind-Lb Clinical Trial Of Neflamapimod For The Treatment Of Patients With Dementia With Lewy Bodies
11/06/2024 13:15
June 11 (Reuters) - CervoMed Inc CRVO.O :
* CERVOMED ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2B
REWIND-LB CLINICAL TRIAL OF NEFLAMAPIMOD FOR THE TREATMENT OF
PATIENTS WITH DEMENTIA WITH LEWY BODIES
Source text for Eikon: ID:nGNX2ndHZw
Further company coverage: CRVO.O
((Reuters.Briefs@thomsonreuters.com;))